Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-02-02

FDA Approved: IMIPRAMINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' supplemental application for imipramine hydrochloride (ANDA 090441), a generic antidepressant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Imipramine hydrochloride (Imipramine hydrochloride)

Snippet

SUPPL AP for IMIPRAMINE HYDROCHLORIDE (IMIPRAMINE HYDROCHLORIDE)